{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T15:06:49Z","timestamp":1761491209570,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.transci.2021.103127","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T12:54:45Z","timestamp":1617454485000},"page":"103127","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience"],"prefix":"10.1016","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5916-0119","authenticated-orcid":false,"given":"Ahmet","family":"Sar\u0131c\u0131","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3285-417X","authenticated-orcid":false,"given":"Mehmet Ali","family":"Erkurt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4045-4555","authenticated-orcid":false,"given":"\u00d6mer Faruk","family":"Bah\u00e7ecio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7498-344X","authenticated-orcid":false,"given":"Soykan","family":"Bi\u00e7im","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3312-8476","authenticated-orcid":false,"given":"\u0130lhami","family":"Berber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selim","family":"G\u00f6k","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8605-8497","authenticated-orcid":false,"given":"Emin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2627-167X","authenticated-orcid":false,"given":"Mustafa","family":"\u00d6zg\u00fcl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6126-0816","authenticated-orcid":false,"given":"\u0130rfan","family":"Kuku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.transci.2021.103127_bib0005","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.bbmt.2014.05.003","article-title":"Peripheral blood progenitor cell mobilization for autologous and allogeneic hematopoietic cell transplantation: guidelines from the American Society for Blood and Marrow Transplantation","volume":"20","author":"Duong","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"10","key":"10.1016\/j.transci.2021.103127_bib0010","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1038\/leu.2009.127","article-title":"International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)","volume":"23","author":"Giralt","year":"2009","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.transci.2021.103127_bib0015","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/bmt.2016.304","article-title":"A single center\u2019s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation","volume":"52","author":"Haverkos","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transci.2021.103127_bib0020","first-page":"78","article-title":"Optimizing stem cells mobilization strategies to ameliorate patient outcomes: a review of guide-lines and recommendations","volume":"11","author":"Mohammadi","year":"2017","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"issue":"3","key":"10.1016\/j.transci.2021.103127_bib0025","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"21","key":"10.1016\/j.transci.2021.103127_bib0030","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.2174\/0929867323666160517115907","article-title":"Biosimilar filgrastim in autologous peripheral blood hematopoietic stem cell mobilization and post-transplant hematologic recovery","volume":"23","author":"Marchesi","year":"2016","journal-title":"Curr Med Chem"},{"issue":"3","key":"10.1016\/j.transci.2021.103127_bib0035","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7150\/thno.7752","article-title":"Biosimilar G-CSF based mobilization of peripheral blood hematopoietic stem cells for autologous and allogeneic stem cell transplantation","volume":"4","author":"Schmitt","year":"2014","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.transci.2021.103127_bib0040","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s12325-014-0114-z","article-title":"Peripheral blood stem cell mobilization and engraftment after autologous stem cell transplantation with biosimilar rhG-CSF","volume":"31","author":"Rem\u00e9nyi","year":"2014","journal-title":"Adv Ther"},{"issue":"2","key":"10.1016\/j.transci.2021.103127_bib0045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/bmt.2009.150","article-title":"Comparison between filgrastim and lenograstim plus chemotherapy for mobilization of PBPCs","volume":"45","author":"Ria","year":"2010","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"10.1016\/j.transci.2021.103127_bib0050","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V98.7.2059","article-title":"Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation","volume":"98","author":"Narayanasami","year":"2001","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.transci.2021.103127_bib0055","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.3324\/haematol.13204","article-title":"Mobilization of peripheral blood stem cells in myeloma with either pegfilgrastim or filgrastim following chemotherapy","volume":"93","author":"Tricot","year":"2008","journal-title":"haematologica"},{"issue":"5-6","key":"10.1016\/j.transci.2021.103127_bib0060","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1080\/10428199909169614","article-title":"Comparison of lenograstim vs filgrastim administration following chemotherapy for peripheral blood stem cell (PBSC) collection: a retrospective study of 126 patients","volume":"35","author":"Lefr\u00e8re","year":"1999","journal-title":"Leuk Lymphoma"},{"issue":"10","key":"10.1016\/j.transci.2021.103127_bib0065","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/trf.14211","article-title":"Comparison of biosimilar filgrastim, originator filgrastim, and lenograstim for autologous stem cell mobilization in patients with multiple myeloma","volume":"57","author":"Lisenko","year":"2017","journal-title":"Transfusion"},{"issue":"2","key":"10.1016\/j.transci.2021.103127_bib0070","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3109\/10428194.2015.1063147","article-title":"Biosimilar filgrastim (Zarzio\u00ae) vs. lenograstim (Myelostim\u00ae) for peripheral blood stem cell mobilization in adult patients with lymphoma and myeloma: a single center experience","volume":"57","author":"Marchesi","year":"2016","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.transci.2021.103127_bib0075","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.transci.2013.04.007","volume":"48","author":"Sivgin","year":"2013","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2021.103127_bib0080","doi-asserted-by":"crossref","first-page":"123","DOI":"10.2147\/JBM.S224173","volume":"11","author":"Restelli","year":"2020","journal-title":"J Blood Med"},{"issue":"2","key":"10.1016\/j.transci.2021.103127_bib0085","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1177\/2040620714565962","article-title":"Use of biosimilar filgrastim compared with lenograstim in autologous haematopoietic stem-cell transplant and in sibling allogeneic transplant","volume":"6","author":"Uddin","year":"2015","journal-title":"Ther Adv Hematol"},{"issue":"6","key":"10.1016\/j.transci.2021.103127_bib0090","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.transci.2017.11.016","article-title":"Biosimilar filgrastim (leucostim\u00ae) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen\u00ae) and lenograstim (granocyte\u00ae): a retrospective multicenter study","volume":"56","author":"Kay\u0131k\u00e7\u0131","year":"2017","journal-title":"Transfus Apher Sci"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000938?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221000938?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:53:21Z","timestamp":1761468801000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221000938"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S1473050221000938"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103127","relation":{},"ISSN":["1473-0502"],"issn-type":[{"type":"print","value":"1473-0502"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lenograstim versus filgrastim in mobilization before autologous hematopoietic stem cell transplantation in patients with multiple myeloma and lymphoma - Single center experience","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103127","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103127"}}